I 
119TH CONGRESS 
1ST SESSION H. R. 2592 
To require the Administrator of the Federal Aviation Administration to pub-
lish the list of medications that the Administrator has compiled for 
purposes of the medical certification of airmen, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
APRIL 2, 2025 
Mr. CASTEN (for himself and Mr. STAUBER) introduced the following bill; 
which was referred to the Committee on Transportation and Infrastructure 
A BILL 
To require the Administrator of the Federal Aviation Admin-
istration to publish the list of medications that the Ad-
ministrator has compiled for purposes of the medical 
certification of airmen, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Aviation Medication 
Transparency Act of 2025’’. 
SEC. 2. LIST OF APPROVED MEDICATIONS. 
(a) IN GENERAL.—Not later than 1 year after the 
date of enactment of this Act, the Administrator of the 
VerDate Sep 11 2014 
22:28 Apr 07, 2025
Jkt 059200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H2592.IH
H2592
ssavage on LAPJG3WLY3PROD with BILLS
Federal Aviation Administration shall publish and main-
tain on a publicly available website of the Administration 
the list of medications and treatments that may be safely 
prescribed to an airman to treat certain medical conditions 
that the Administrator has compiled for purposes of the 
issuance of a medical certification to an airman. 
(b) REQUIREMENTS.—The list required under sub-
section (a) shall— 
(1) be drafted in consultation with— 
(A) the Aeromedical Innovation and Mod-
ernization Working Group; 
(B) the certified exclusive bargaining rep-
resentatives of air traffic controllers of the Ad-
ministration certified under section 7111 of 
title 5, United States Code; 
(C) the principal organization representing 
the largest certified collective bargaining rep-
resentative of airline pilots; and 
(D) any other stakeholder determined rel-
evant by the task group, including any stake-
holders described in section 411(d)(3)(B) of the 
FAA Reauthorization Act of 2024; 
(2) be comprehensive; 
(3) be drafted in a user-friendly and accessible 
manner and provided to airmen at the time when 
VerDate Sep 11 2014 
22:28 Apr 07, 2025
Jkt 059200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H2592.IH
H2592
ssavage on LAPJG3WLY3PROD with BILLS
such airmen first seek a license and medical certifi-
cation; 
(4) indicate what, if any, period of time, on av-
erage, an airman must have limited or no duties to 
stabilize on an approved medication; 
(5) include the list of medications that the Ad-
ministrator has designated as ‘‘Do Not Issue’’; 
(6) include a mechanism for doctors or medical 
providers to contact the Federal Aviation Adminis-
tration regarding questions related to such list; 
(7) include any additional information that the 
Administrator determines is appropriate to provide 
with respect to what conditions a certain medication 
may or may not be used to treat and any informa-
tion to explain why a medication is allowed or pro-
hibited by the Federal Aviation Administration; and 
(8) include any other information or clarifica-
tion that the Administrator determines appropriate. 
(c) ANNUAL UPDATE.—Not later than 1 year after 
the date of publication of the list required under sub-
section (a), and annually thereafter, the Administrator 
shall update such list, as appropriate. 
Æ 
VerDate Sep 11 2014 
22:28 Apr 07, 2025
Jkt 059200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\H2592.IH
H2592
ssavage on LAPJG3WLY3PROD with BILLS